(Kocaeli Üniversitesi, Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Kocaeli, TÜRKİYE)
(Kocaeli Üniversitesi, Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Kocaeli, TÜRKİYE)
(Kocaeli Üniversitesi, Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Kocaeli, TÜRKİYE)
(Kocaeli Üniversitesi, Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Kocaeli, TÜRKİYE)
Yıl: 2021Cilt: 27Sayı: 1ISSN: 1300-6045 / 1309-2251Sayfa Aralığı: 51 - 56İngilizce

60 0
In Vitro Eff ect of Pelargonium sidoides on Promastigote Forms of Leishmania infantum and Leishmania tropica
Leishmaniasis is recognized as a neglected disease by the World Health Organization (WHO). New treatment modalities are needed for the treatment of leishmaniasis due to the limited number of drugs that can cause toxic side eff ects. Therefore, studies are being carried out on herbal extracts, which can be potential candidates for the treatment. Pelargonium sidoides a perennial herb originating in Africa, is used to treat infectious diseases. The aim of this study was to perform in vitro investigation of the direct eff ect of P. sidoides commercially available root extract (EPs 7630) on promastigotes of Leishmania infantum and Leishmania tropica. For this purpose, L. infantum and L. tropica strains were grown on NNN medium and then transferred into RPMI 1640 medium supported by 10% fetal bovine serum. After mass growing, the promastigotes were placed into 96-well plates with L. infantum as 5x104 and L. tropica as 1.5x105 . EPs 7630 was diluted at a concentration of 400, 200, 100 and 50 µg/mL. Afterwards, EPs 7630 was added and then counted by hemocytometry at 24, 48, 72, and 96 h. The calculations were done after the experiments repeated three times. Comparison with the control group and liposomal amphotericin B showed that EPs 7630 had no inhibitory eff ect on the growth of Leishmania promastigotes at the concentrations of 50 and 100 µg/mL, a partial inhibitory eff ect at 200 µg/mL, and an inhibitory eff ect at 400 µg/mL. It was concluded that identifying the substance(s) responsible for the antileishmanial eff ect of P. sidoides extract, conducting toxicity studies, and improving the results of these studies in in vivo models may be useful as steps for future clinical studies.
DergiAraştırma MakalesiErişime Açık
  • 1. Maxfield L, Crane JS: Leishmaniasis. In, StatPearls [Internet]. Treasure Island (FL): StatPearls Available from: books/NBK531456/?report=classic; Accessed: 25.09.2020.
  • 2. Lévêque MF, Lachaud L, Simon L, Battery E, Marty P, Pomares, C: Place of serology in the diagnosis of zoonotic leishmaniases with a focus on visceral leishmaniasis due to Leishmania infantum. Front Cell Infect Microbiol, 10:67, 2020. DOI: 10.3389/fcimb.2020.00067
  • 3. Thakur S, Joshi J, Kaur S: Leishmaniasis diagnosis: An update on the use of parasitological, immunological and molecular methods. J Parasit Dis, 44 (2): 253-272, 2020. DOI: 10.1007/s12639-020-01212-w
  • 4. Serban G: Future prospects in the treatment of parasitic diseases: 2-Amino-1,3,4-Thiadiazoles in leishmaniasis. Molecules, 24:1557, 2019. DOI: 10.3390/molecules24081557
  • 5. Battista T, Colotti G, Ilari A, Fiorillo A: Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases. Molecules, 25:1924, 2020. DOI: 10.3390/molecules25081924
  • 6. Basmaciyan L, Casanova M: Cell death in Leishmania. Parasite, 26:71, 2019. DOI: 10.1051/parasite/2019071
  • 7. Neto RNM, Setúbal RFB, Higino TMM, Brelaz-De-Castro MCA, Da Silva LCN, Dos Santos Aliança AS: Asteraceae plants as sources of compounds against leishmaniasis and chagas disease. Front Pharmacol, 10:477, 2019. DOI: 10.3389/fphar.2019.00477
  • 8. Moafi M, Rezvan H, Sherkat R, Taleban R: Leishmania vaccines entered in clinical trials: A review of literature. Int J Prev Med, 10:95, 2019. DOI: 10.4103/ijpvm.IJPVM_116_18
  • 9. Karamysheva ZN, Guarnizo, SAG, Karamyshev AL: Regulation of translation in the protozoan parasite leishmania. Int J Mol Sci, 21:2981, 2020. DOI: 10.3390/ijms21082981
  • 10. Narayan S, Thakur CP, Bahadur S, Thakur M, Pandey SN, Thakur AK, Mitra DK, Mukherjee PK: Cedrus deodara: In vitro antileishmanial efficacy & immumomodulatory activity. Indian J Med Res, 146 (6): 780-787, 2017. DOI: 10.4103/ijmr.IJMR_959_16
  • 11. World Health Organization: Weekly Epidemiological Record. 93, 521-540, 2018. hastaliklar-db/zoonotik-hastaliklar/3-Sark-cibani/4-Kitap- Makaleler/DSO_WER_Makale.pdf; Accessed: 25.11.2020.
  • 12. Moyo M, Van Staden J: Medicinal properties and conservation of Pelargonium sidoides DC. J Ethnopharmacol, 152 (2): 243-255, 2014. DOI: 10.1016/j.jep.2014.01.009
  • 13. Careddu D, Pettenazzo A: Pelargonium sidoides extract EPs 7630: A review of its clinical efficacy and safety for treating acute respiratory tract infections in children. Int J Gen Med, 11, 91-98, 2018. DOI: 10.2147/IJGM. S154198
  • 14. Zahir AA, Rahuman AA, Pakrashi S, Ghosh D, Bagavan A, Kamaraj C, Elango G, Chatterjee M: Evaluation of antileishmanial activity of South Indian medicinal plants against Leishmania donovani. Exp Parasitol, 132 (2): 180-184, 2012. DOI: 10.1016/j.exppara.2012.06.012
  • 15. Hubert DJ, Céline N, Michel N, Gogulamudi VR, Florence NT, Johnson BN, Bonaventure NT, Singh IP, Sehgal R: In vitro leishmanicidal activity of some Cameroonian medicinal plants. Exp Parasitol, 134 (3): 304-308, 2013. DOI: 10.1016/j.exppara.2013.03.023
  • 16. Mansour R, Haouas N, Kahla-Nakbi AB, Hammami S, Mighri Z, Mhenni F, Babba H: The Effect of Vitis vinifera L. Leaves extract on Leishmania infantum. Iran J Pharm Res, 12 (3): 349-355, 2013. DOI: 10.22037/ ijpr.2013.1333
  • 17. de Medeiros MDGF, da Silva AC, Citó AMGL, Borges AR, de Lima SG, Lopes JAD, Figueiredo RCBQ: In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham. Parasitol Int, 60 (3): 237-241, 2011. DOI: 10.1016/j.parint.2011.03.004
  • 18. Mahmoudvand H, Sepahvand P, Jahanbakhsh S, Azadpour M: Evaluation of the antileishmanial and cytotoxic effects of various extracts of garlic (Allium sativum) on Leishmania tropica. J Parasit Dis, 40 (2): 423- 426, 2016. DOI: 10.1007/s12639-014-0520-9
  • 19. Mohammad BI, Al Shammary MN, Abdul Mageed RH, Yousif NG: Herbal extract targets in Leishmania tropica. J Parasit Dis, 39 (4): 663-672, 2015. DOI: 10.1007/s12639-014-0436-4
  • 20. Piñero JE, Martínez S, del Castillo A, Portús M, Valladares B: In vitro susceptibility of Leishmania infantum strains isolated from Spanish HIV-positive patients to Abelcet and Fungizone. J Antimicrob Chemother, 50 (2): 304-306, 2002. DOI: 10.1093/jac/dkf113
  • 21. Thäle C, Kiderlen AF, Kolodziej H: Anti-Infective activities of Pelargonium sidoides (EPS® 7630): Effects of induced NO production on Leishmania major in infected macrophages and antiviral effects as assessed in a fibroblast-virus protection assay. Planta Med, 77 (7): 718- 725, 2011. DOI: 10.1055/s-0030-1250567
  • 22. Kolodziej H: Antimicrobial, antiviral and immunomodulatory activity studies of Pelargonium sidoides (EPs® 7630) in the context of health promotion. Pharmaceuticals, 4 (10): 1295-1314, 2011. DOI: 10.3390/ph4101295
  • 23. European Medicines Agency Science Medicines Health: Assessment report on Pelargonium sidoides DC and/or Pelargonium reniforme Curt., radix, EMA/HMPC/444251/2015. herbal-report/final-assessment-report-pelargonium-sidoides-dc/ pelargonium-reniforme-curt- radix-revision-1_en.pdf; Accessed: 25.09.2020.
  • 24. Kolodziej H: Aqueous ethanolic extract of the roots of Pelargonium sidoides-new scientific evidence for an old anti-infective phytopharmaceutical. Planta Med, 74 (6): 661-666, 2008. DOI: 10.1055/s-2007-993778
  • 25. Soosaraei M, Fakhar M, Hosseini Teshnizi S, Ziaei Hezarjaribi H, Banimostafavi ES: Medicinal plants with promising antileishmanial activity in Iran: A systematic review and meta-analysis. Ann Med Surg, 21, 63-80, 2017. DOI: 10.1016/j.amsu.2017.07.057

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.